CIK 0001750284
- Non-accelerated filer
- Smaller reporting company
Olema Oncology, Inc.
Sign in to watch- Ticker
- OLMA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 300409740
- Phone
- +1 415-651-3316
- Business address
- 365 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Olema Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-02 | Zojwalla Naseem CHIEF MEDICAL OFFICER | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2026-02-02 | Zojwalla Naseem CHIEF MEDICAL OFFICER | Grant or award · Performance Stock Options (Right to Buy) | +106,250 | 106,250 | ||
| 2025-12-23 | Zojwalla Naseem Chief Medical Officer | Exercise or conversion | +50,000 | $7.02 | $351K | 103,997 |
| 2025-12-23 | Zojwalla Naseem Chief Medical Officer | Sale | −99,509 | $27.66 | $2.8M | 4,488 |
| 2025-12-23 | Zojwalla Naseem Chief Medical Officer | Exercise or conversion · Stock Option (Right to Buy) | −50,000 | 156,818 | ||
| 2025-12-22 | Zojwalla Naseem Chief Medical Officer | Exercise or conversion | +42,818 | $15.25 | $653K | 146,815 |
| 2025-12-22 | Zojwalla Naseem Chief Medical Officer | Exercise or conversion | +7,182 | $7.02 | $50K | 153,997 |
| 2025-12-22 | Zojwalla Naseem Chief Medical Officer | Sale | −100,000 | $28.04 | $2.8M | 53,997 |
| 2025-12-22 | Zojwalla Naseem Chief Medical Officer | Exercise or conversion · Stock Option (Right to Buy) | −42,818 | 112,182 | ||
| 2025-12-22 | Zojwalla Naseem Chief Medical Officer | Exercise or conversion · Stock Option (Right to Buy) | −7,182 | 206,818 | ||
| 2025-12-19 | Zojwalla Naseem Chief Medical Officer | Exercise or conversion | +40,000 | $15.25 | $610K | 173,997 |
| 2025-12-19 | Zojwalla Naseem Chief Medical Officer | Sale | −57,079 | $28.03 | $1.6M | 116,918 |
| 2025-12-19 | Zojwalla Naseem Chief Medical Officer | Sale | −12,921 | $28.93 | $374K | 103,997 |
| 2025-12-19 | Zojwalla Naseem Chief Medical Officer | Exercise or conversion · Stock Option (Right to Buy) | −40,000 | 155,000 | ||
| 2025-02-28 | Zojwalla Naseem CHIEF MEDICAL OFFICER | Grant or award · Stock Option (Right to Buy) | +205,000 | 205,000 | ||
| 2024-12-16 | Zojwalla Naseem CHIEF MEDICAL OFFICER | Exercise or conversion | +14,000 | $4.87 | $68K | 129,509 |
| 2024-12-16 | Zojwalla Naseem CHIEF MEDICAL OFFICER | Exercise or conversion · Stock Option (Right to Buy) | −14,000 | 112,840 | ||
| 2024-12-11 | Zojwalla Naseem CHIEF MEDICAL OFFICER | Sale | −14,202 | $8.66 | $123K | 115,829 |
| 2024-12-11 | Zojwalla Naseem CHIEF MEDICAL OFFICER | Sale | −320 | $9.39 | $3K | 115,509 |
| 2024-12-10 | Zojwalla Naseem CHIEF MEDICAL OFFICER | Sale | −13,283 | $9.37 | $124K | 130,031 |
Page 1 of 2 · 38 trades